CAAS CAPITAL MANAGEMENT LP - ADC THERAPEUTICS SA ownership

ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 58 filers reported holding ADC THERAPEUTICS SA in Q4 2021. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.

Quarter-by-quarter ownership
CAAS CAPITAL MANAGEMENT LP ownership history of ADC THERAPEUTICS SA
ValueSharesWeighting
Q4 2021$262,000
-77.3%
12,958
-63.0%
0.01%
-77.8%
Q3 2020$1,155,000
-29.5%
35,0000.0%0.03%
-50.0%
Q2 2020$1,638,00035,0000.05%
Other shareholders
ADC THERAPEUTICS SA shareholders Q4 2021
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 1,186,215$4,555,0662.69%
Blue Owl Capital Holdings LP 733,568$2,816,9011.20%
Redmile Group, LLC 7,590,849$29,148,8601.19%
AlphaCentric Advisors LLC 297,500$1,142,4001.13%
Prosight Management, LP 463,310$1,779,1100.97%
GCM Grosvenor Holdings, LLC 735,471$2,824,2090.72%
Indie Asset Partners, LLC 93,839$360,3420.40%
XTX Topco Ltd 197,635$758,9180.16%
Eventide Asset Management 1,879,959$7,219,0430.14%
Nantahala Capital Management 243,290$934,2340.06%
View complete list of ADC THERAPEUTICS SA shareholders